CareDx, Inc.

About CareDx, Inc.

CareDx, Inc. is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It develops and markets non-invasive diagnostics that use cell-free DNA to monitor organ rejection and transplant health, including AlloSure for kidney, AlloMap Heart, and AlloSure Lung tests. The company also offers AlloCare patient app and RemoTrac mobile phlebotomy services to support remote monitoring and improve patient adherence. CareDx serves transplant centers, physicians, and patients across the United States and internationally, aiming to enhance long-term outcomes and quality of life for transplant recipients.